Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

824
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
824
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.7K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

186
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
186
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

1.1K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025-2026.

Vaccine·2026
Same author

Geriatrics co-management of the vulnerable older surgical patient.

Gerontology·2026
Same author

Dementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stay : A Target Trial Emulation.

Annals of internal medicine·2026
Same author

Respiratory surveillance through point of care molecular testing and its impacts on nursing home RSV, influenza, and SARS-CoV-2 awareness and reporting behavior: a pilot study.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis.

JAMA network open·2026
Same author

Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccination.

iScience·2026

Related Experiment Video

Updated: Apr 18, 2026

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

973

Transdermal Buprenorphine for Pain Management in Older Patients With Multiple Rib Fractures.

Iva Neupane1, Brian Mikolasko1, Charles A Adams2

  • 1Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Journal of the American Geriatrics Society
|April 17, 2026
PubMed
Summary

Transdermal buprenorphine in older adults with rib fractures reduced opioid and naloxone use for acute pain management. This suggests a favorable safety and analgesic profile, though further randomized trials are needed.

Keywords:
mortalityopioid analgesicspain managementrespiratory depression

More Related Videos

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

8.3K
A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat
13:27

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat

Published on: October 6, 2018

8.7K

Related Experiment Videos

Last Updated: Apr 18, 2026

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

973
Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

8.3K
A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat
13:27

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat

Published on: October 6, 2018

8.7K

Area of Science:

  • Trauma Surgery
  • Pain Management
  • Geriatric Medicine

Background:

  • Older trauma patients with rib fractures face higher morbidity and mortality.
  • Effective pain control is crucial but challenging due to increased adverse event risk in this population.
  • Transdermal buprenorphine's role in managing acute pain in elderly patients with rib fractures is under-researched.

Purpose of the Study:

  • To evaluate the effectiveness and safety of transdermal buprenorphine for pain management in older adults with multiple rib fractures.
  • To compare opioid consumption and other clinical outcomes between patients receiving transdermal buprenorphine and those who did not.

Main Methods:

  • Retrospective cohort study of 779 patients aged 65 years or older admitted with multiple rib fractures.
  • Comparison of outcomes between patients who received transdermal buprenorphine and those who did not.
  • Primary outcome: oral morphine equivalent consumption; Secondary outcomes: analgesic use, naloxone administration, length of stay, complications, mortality, and readmission rates.

Main Results:

  • 16.4% of patients received transdermal buprenorphine; they were older and had higher comorbidities.
  • No significant difference in total hospital opioid use, but second-day and overall opioid requirements post-patch application were significantly lower in the buprenorphine group.
  • No naloxone use in the buprenorphine group versus 1.1% in the non-buprenorphine group; no significant differences in other secondary outcomes.

Conclusions:

  • Transdermal buprenorphine use in older trauma patients with rib fractures was associated with reduced opioid and naloxone requirements.
  • The treatment suggests a favorable safety and analgesic profile for acute pain management in this demographic.
  • Further investigation via randomized controlled trials is recommended to confirm these findings.